The melanoma patient cohort in TCGA was divided into two clusters according to the NFATC4 target genes expression patterns, and the patient cluster with a high expression of NFATC4 target genes had a lower survival rate (Figure 6E, F and Figure 6—figure supplement 1A, B). Here, NFATC4 is linked to melanoma.